TREATING DIABETES MELLITUS WITH LONG-ACTING INSULIN FORMULATIONS Russian patent published in 2019 - IPC A61K38/28 A61K9/00 A61P3/10 

FIELD: medicine; pharmaceuticals.

SUBSTANCE: present invention refers to pharmaceutical industry, namely to a method for treating type I or type II diabetes mellitus. Method of treating type I or type II diabetes mellitus, comprising administering the aqueous pharmaceutical formulation once a day, where the time interval after the previous administration is in range of 24.5 h to 28 h or in range of 20 h to 23.5 h for at least two days a week, and where the average time interval after the previous administration is approximately 24 hours, where composition contains 300 IU/ml of glargine insulin [equimolarly 300 IU of human insulin].

EFFECT: presented method of treating type I or type II diabetes mellitus is effective, safe and reduces a risk of developing nocturnal hypoglycaemia.

12 cl, 15 dwg, 76 tbl, 6 ex